Skip to Main Content


Skip Nav Destination

Ask the Hematologists

Since monoclonal B-cell lymphocytosis is frequently encountered in hematologic practice, a detailed discussion of that condition is warranted. Read More

Issue Cover
Current Issue
Volume 20,
Issue 5,
September-October 2023

Featured Content

Mentoring Makes the Difference

Four mentor-mentee pairs share their experiences as part of a program under ASH’s Minority Recruitment Initiative, which turns 20 this year.

MEN1 Mutations Induce Acquired Resistance to the Menin Inhibitor Revumenib

Contributing Editor Christine McMahon, MD, shares her insights on a study that assesses the mechanisms underlying acquired resistance to revumenib.

Rilzabrutinib for Persistent ITP: New Kid on the Block?

Researchers are studying the efficacy of rilzabrutinib for the treatment of primary, persistent immune thrombocytopenia.

Close Modal

or Create an Account

Close Modal
Close Modal